Despite the good results for avoiding OHSS, the first reports from prospective randomised clinical trials which explored the reproductive outcome after GnRH analogue triggering revealed a poor clinical outcome when the GnRH agonist was used, in addition to a high early pregnancy loss rate despite supplementing the luteal phase with progesterone and oestradiol. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.